Form 4: Vita Coco CEO Sells Shares Under 10b5-1 Plan

Vita Coco Company CEO Martin Roper and affiliated trusts sold 7,894 shares of common stock for approximately $337,823 under a pre-arranged trading plan.

Summary

• Martin Roper, Chief Executive Officer and Director of Vita Coco Company, Inc. (COCO), reported the sale of common stock.
• A total of 7,894 shares of common stock were sold on October 7, 2025, through direct and indirect holdings.
• The sales were executed pursuant to a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction.
• Direct holdings decreased by 1,835 shares, sold at a weighted average price of $42.745 per share, with prices ranging from $42.64 to $42.88.
• Indirect holdings through the Christopher G. Roper Exempt Family Trust decreased by 2,275 shares, sold at a weighted average price of $42.83 per share, with prices ranging from $42.64 to $42.90.
• Indirect holdings through the Peter S. Roper Exempt Family Trust decreased by 1,384 shares, sold at a weighted average price of $42.75 per share, with prices ranging from $42.51 to $42.91.
• Indirect holdings through the Thomas L. Roper Exempt Family Trust decreased by 2,400 shares, sold at a weighted average price of $42.773 per share, with prices ranging from $42.51 to $42.90.
• Following these transactions, Martin Roper directly beneficially owns 287,062 shares of common stock.
• Each of the Christopher G. Roper Exempt Family Trust, Peter S. Roper Exempt Family Trust, and Thomas L. Roper Exempt Family Trust indirectly beneficially owns 221,131 shares of common stock.
• An additional 61,200 shares are indirectly beneficially owned by Martin Roper's spouse.
• Martin Roper also holds several non-qualified stock options, including 579,670 options exercisable at $10.178 (fully vested) and 40,950 options exercisable at $10.178 (fully vested).
• Other stock options include 298,507 at $15 (vesting began Nov 27, 2022), 46,875 at $16.91 (vesting began Mar 10, 2024), 62,743 at $26.18 (vesting began Mar 4, 2025), and 70,715 at $32.78 (vesting begins Mar 3, 2026).

Sentiment

Score: 5

Explanation: The filing reports pre-planned insider sales under a Rule 10b5-1 plan, which is a neutral event, though it represents a reduction in beneficial ownership by the CEO and related trusts. It does not indicate a change in company fundamentals.

Positives

• The sales were conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled divestment rather than a reaction to recent company news or performance.
• The average sale prices for the common stock were relatively high, ranging from $42.745 to $42.83, reflecting a strong market valuation for the shares at the time of sale.

Negatives

• The transactions represent a reduction in the beneficial ownership of common stock by the Chief Executive Officer and affiliated family trusts, which can sometimes be perceived as a negative signal by investors.
• A total of 7,894 shares were divested, reducing the insider's direct and indirect stake in the company.

Future Outlook

This Form 4 filing primarily reports insider transactions and does not contain any forward-looking statements or guidance regarding the company's future performance or strategic outlook.

Management Comments

• The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

Industry Context

This filing is a routine insider transaction report and does not provide information that directly relates to broader industry trends or competitive landscape analysis for the beverage sector.

Related Party Transactions

• Sales of common stock were made by the Christopher G. Roper Exempt Family Trust, Peter S. Roper Exempt Family Trust, and Thomas L. Roper Exempt Family Trust, which are affiliated with the reporting person, Martin Roper.

Stakeholder Impact

• Shareholders may note the reduction in direct and indirect beneficial ownership by the CEO and affiliated trusts, although the sales were pre-planned under a 10b5-1 plan.

Key Dates

Recommendation

The reported sales by the CEO and affiliated trusts were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a scheduled divestment rather than a reaction to new information. While it reduces insider ownership, it does not inherently signal a change in the company's fundamental outlook or warrant a change in investment thesis based solely on this filing. Therefore, a 'hold' recommendation is appropriate as this event alone does not provide a strong catalyst for a 'buy' or 'sell' decision.

Keywords

Vita Coco, COCO, Insider Trading, Form 4, Martin Roper, Stock Sale, 10b5-1 Plan, CEO, Beneficial Ownership, Stock Options